Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
450.5 USD | +0.66% | +2.24% | +10.72% |
05-22 | Vertex Pharmaceuticals Insider Sold Shares Worth $6,795,294, According to a Recent SEC Filing | MT |
05-21 | ADDvise Group’s Axelerist Bags $1.4 Million Order for Medical, Lab Equipment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.72% | 115B | |
+11.51% | 106B | |
-6.11% | 24.69B | |
-2.33% | 21.97B | |
-6.03% | 19.27B | |
-13.27% | 17.56B | |
-40.50% | 17.32B | |
+6.48% | 14.03B | |
+31.67% | 12.13B | |
-34.34% | 7.77B |
- Stock Market
- Equities
- VRTX Stock
- News Vertex Pharmaceuticals Incorporated
- Piper Sandler Adjusts Price Target on Vertex Pharmaceuticals to $296 From $293, Maintains Neutral Rating